Sources: Global Glucagon-like Peptide 1 (GLP-1) Market Analysis Report 2023: Potential Clinical Application of GLP-1 Receptor Agonists For the Treatment of NASH Gaining Momentum. GlobeNewswire, January 30, 2023
While many people follow a GLP-1 diet to support weight loss, the same nutritional principles can also help people taking GLP-1 medications for type 2 diabetes or other medical reasons
Semaglutide titration: 0.25mg to 2.4mg The semaglutide titration schedule moves through five dose levels over approximately 16-20 weeks: Weeks 1-4: 0.25mg weekly Weeks 5-8: 0.5mg weekly Weeks 9-12: 1.0mg weekly Weeks 13-16: 1.7mg weekly Week 17 onward: 2.4mg weekly (maintenance dose) Each increase happens monthly
Researchers continue to examine how GLP-1s might affect a persons health beyond type 2 diabetes management and weight loss
These medications include semaglutide (Ozempic, Wegovy) and dulaglutide (Trulicity) for both diabetes and weight management, and liraglutide (Victoza for diabetes, Saxenda for weight management)
Digestive changes including constipation or diarrhea may occur as GLP-1 medications slow gastric emptying
